Milatuzumab-Sn-38 Conjugates for the Treatment of CD74+ Cancers
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-1170
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2013
Authors
Publisher
American Association for Cancer Research (AACR)